Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at Wall Street Zen

Wall Street Zen began coverage on shares of Retractable Technologies (NYSE:RVP) in a research note published on Thursday morning. The firm issued a hold rating on the stock.

Retractable Technologies Trading Up 1.4%

NYSE RVP opened at $0.65 on Thursday. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01. The company has a market cap of $19.43 million, a price-to-earnings ratio of -1.20 and a beta of 1.65. The business has a 50 day moving average price of $0.72 and a 200-day moving average price of $0.72. Retractable Technologies has a 52 week low of $0.56 and a 52 week high of $1.22.

Insider Activity

In other news, CEO Thomas J. Shaw acquired 86,014 shares of Retractable Technologies stock in a transaction dated Thursday, May 15th. The shares were purchased at an average cost of $0.75 per share, for a total transaction of $64,510.50. Following the transaction, the chief executive officer now owns 15,376,794 shares of the company’s stock, valued at $11,532,595.50. This trade represents a 0.56% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. In the last three months, insiders have bought 217,204 shares of company stock worth $157,820. 57.10% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. Wealthfront Advisers LLC acquired a new stake in shares of Retractable Technologies, Inc. (NYSE:RVP) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 2,533,952 shares of the company’s stock, valued at approximately $1,748,000. Wealthfront Advisers LLC owned about 8.46% of Retractable Technologies at the end of the most recent quarter. Hedge funds and other institutional investors own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.